Insider Transactions in Q3 2025 at Akoya Biosciences, Inc. (AKYA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 08
2025
|
John Frederick Ek CFO |
SELL
Other acquisition or disposition
|
Indirect |
20,000
-100.0%
|
-
|
|
Jul 08
2025
|
John Frederick Ek CFO |
SELL
Other acquisition or disposition
|
Direct |
248,202
-60.97%
|
-
|
|
Jul 08
2025
|
Jennifer Kamocsay Chief Legal Officer |
SELL
Other acquisition or disposition
|
Direct |
179,272
-54.68%
|
-
|
|
Jul 08
2025
|
Brian Mc Kelligon President and CEO |
SELL
Other acquisition or disposition
|
Direct |
947,688
-100.0%
|
-
|
|
Jul 08
2025
|
Brian Mc Kelligon President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
196,866
-17.2%
|
-
|
|
Jul 08
2025
|
Brian Mc Kelligon President and CEO |
BUY
Other acquisition or disposition
|
Direct |
724,428
+27.52%
|
-
|
|
Jul 08
2025
|
Niro Ph.D Ramachandran Chief Business Officer |
SELL
Other acquisition or disposition
|
Direct |
282,555
-76.89%
|
-
|
|
Jul 08
2025
|
Niro Ph.D Ramachandran Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,148
-12.98%
|
-
|
|
Jul 08
2025
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Other acquisition or disposition
|
Direct |
62,566
+16.16%
|
-
|
|
Jul 08
2025
|
Scott Mendel Director |
SELL
Other acquisition or disposition
|
Direct |
28,500
-100.0%
|
-
|
|
Jul 08
2025
|
Goldman Myla Lai Director |
SELL
Other acquisition or disposition
|
Direct |
20,000
-100.0%
|
-
|
|
Jul 08
2025
|
Thomas A. Raffin Director |
SELL
Other acquisition or disposition
|
Indirect |
17,909,839
-100.0%
|
-
|
|
Jul 08
2025
|
Matthew Winkler Director |
SELL
Other acquisition or disposition
|
Direct |
984,513
-100.0%
|
-
|
|
Jul 08
2025
|
Pascal Bamford Chief Clinical Officer |
SELL
Other acquisition or disposition
|
Direct |
205,738
-52.31%
|
-
|